Categories: Research

Kotis joins leadership of UCSF Health as chief pharmacy executive7

Desi Kotis, PharmD, is committed to bringing the highest level of pharmacy care to patients at UCSF Health.

Update from the Dean: Back to school8

Dean Guglielmo provides updates on ongoing efforts with science, education, and patient care in the School.

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab9

School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.

Dozens of presumed inactive ingredients may impact human biology10

School scientists identify excipients with potential to cause side effects

The Kidney Project wins KidneyX Award to enable simpler, safer at-home dialysis11

School's efforts to develop artificial kidney receive $500,000 boost

How targeting a key SARS-CoV-2 enzyme could lead to an antiviral drug12

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show13

UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory14

The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

Update from the Dean: Building community while staying safe15

Our COVID-19 response: As we return to campus, everyone’s well-being is our top concern. But we also need to consider the need to maintain and strengthen community.

Study on roots of asthma hints at potential of ‘birth cohort’ project16

By studying the health of Puerto Ricans from birth, researchers hope to discover more about causes of asthma.

Pages